comprehensive -WSS

comprehensive

author：fashion 2025-08-31 01:53:05 - browse：66896

Rising drug prices —Medicare coverage from STAT — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start. APStock

WASHINGTON — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start.

Medicare released an initial outline of how the program will work in March. Some parts, including the outline of how drugs would be selected for the negotiation process, were immediately final. The agency asked drug companies, patients, and other affected parties to weigh in on other parts about how the process would proceed, what factors would be considered, and how drugmakers would be held accountable.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care

Please enter a valid email address. Privacy Policy

The negotiation process was created last August in Democrats’ drug pricing reform law, and Medicare is supposed to select the first 10 drugs that will be subject to negotiation by Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Where are patients getting their prescriptions for GLP

WSS

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Obesity drugs seen as possible treatment for liver disease MASH

Community Health Systems hospitals under DOJ investigation

The Harvard botanist who searched for psychedelics in the Amazon

STAT readers on older presidents, polypills, Medicare, and more

After John Oliver segment, STAT readers share their opioid

entertainment

comprehensive

Sign up for D.C. Diagnosis

leisure time

Supreme Court strikes down use of affirmative action

TB outbreak tied to bone grafts underscores testing shortcomings

Trump demands the U.S. pay no more for drugs than other countries … again

Listen: Your guide to Wegovy's blockbuster heart study

FDA approval of Sarepta Duchenne genetic therapy gives me hope

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

Hepatitis C has a cure — but many Americans still lack access to it

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

Moonlake's readout produced a cash windfall. Risks remain

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

leisure time

Large hospital system sues Multiplan for low

Timeline: Special counsel's investigation into Trump's handling of classified documents

Kim Kardashian sparks debate on benefits of full

Faced with fears of OxyContin misuse, sales reps touted its safety

Target recalls 2.2 million additional candles due to laceration, burn hazards

New documents shed light on MD Anderson Cancer Institute feud

knowledge

hotspot

focus

Wikipedia